Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Donjay, feels like dejavu 2013 during the transition from Moore to O'Connor when existing shareholders nearly got wiped out. Hard not to be cynical having been invested more than eight years across now three CEOs and an ICEO and the only ones who have benefited financially are management despite the company advancing to late stage, while investors who have funded the company seen 80% of their capital destroyed.